Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences

• Asıl Yazarlar: Marilia Barreca (Yazar), Noémie Lang (Yazar), Chiara Tarantelli (Yazar), Filippo Spriano (Yazar), Paola Barraja (Yazar), Francesco Bertoni (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Open Exploration Publishing Inc., 2022-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Antibody-drug conjugates (ADCs) are a recent, revolutionary approach for malignancies treatment, designed to provide superior efficacy and specific targeting of tumor cells, compared to systemic cytotoxic chemotherapy. Their structure combines highly potent anti-cancer drugs (payloads or warheads) a...